Evaluation of Some Prognostic Factors in Acute Aluminum Phosphide Intoxicated Cases

Aluminum Phosphide Poisoning Clinical Trial

Official title:
Evaluation of Some Prognostic Factors in Acute Aluminum Phosphide Intoxicated Cases

Status Completed

Clinical Trial Summary

study of some laboratory and clinical findings which may show the severity of aluminium phosphide toxicity and the need of the cases to be admitted to ICU

Clinical Trial Description

aluminium phosphide poisoning is a major cause of death in intoxicated and suicidal cases since there is no antidote and there is no specific investigation for it so there is a need for further study to identify the cause of death and the most specific investigation in the case of AlP toxicity ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05215444
Study type	Observational
Source	Zagazig University
Contact
Status	Completed
Phase
Start date	January 1, 2021
Completion date	June 30, 2021

View Details

See also
	Status	Clinical Trial	Phase
	Completed	`NCT04724655` - Paraffin Oil or Coconut Oil in Acute Aluminum Phosphide Poisoning	Early Phase 1
	Not yet recruiting	`NCT04702906` - Trimetazidine As a Potential Adjuvant Therapy in Acute Aluminum Phosphide Poisoning-induced Cardiotoxicity	N/A